#8B;(1-R)-(1,3,5/2,4)-2,3,4-TRIHYDROXY-5-HYDROXYMETHYL-N-[(1-S)-(1,4,6/5)-6-O-(BETA-D-GLUCOPYRANOSYL)-3-HYDROXYMETHYL-4,5-DIHYDROXYCYCLOHEX-2-ENYL]-CYCLOHEXYLA
Compound with spectra: 1 NMR
![#8B;(1-R)-(1,3,5/2,4)-2,3,4-TRIHYDROXY-5-HYDROXYMETHYL-N-[(1-S)-(1,4,6/5)-6-O-(BETA-D-GLUCOPYRANOSYL)-3-HYDROXYMETHYL-4,5-DIHYDROXYCYCLOHEX-2-ENYL]-CYCLOHEXYLA](/api/compound/66iKiJWJ3eY.png?ph=true&h=300&w=458 "#8B;(1-R)-(1,3,5/2,4)-2,3,4-TRIHYDROXY-5-HYDROXYMETHYL-N-[(1-S)-(1,4,6/5)-6-O-(BETA-D-GLUCOPYRANOSYL)-3-HYDROXYMETHYL-4,5-DIHYDROXYCYCLOHEX-2-ENYL]-CYCLOHEXYLA")
| SpectraBase Compound ID | 66iKiJWJ3eY |
|---|---|
| InChI | InChI=1S/C20H35NO13/c22-3-6-1-8(13(27)15(29)11(6)25)21-9-2-7(4-23)12(26)17(31)19(9)34-20-18(32)16(30)14(28)10(5-24)33-20/h2,6,8-32H,1,3-5H2/t6-,8-,9-,10+,11-,12+,13+,14+,15+,16-,17-,18+,19-,20-/m0/s1 |
| InChIKey | ZJUDLLDHCAQBPD-COTNLMCJSA-N |
| Mol Weight | 497.5 g/mol |
| Molecular Formula | C20H35NO13 |
| Exact Mass | 497.21084 g/mol |
| Enantiomer InChIKey | ZJUDLLDHCAQBPD-VCGQMRDSSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | D2O |
2-O-BETA-D-GLUCOPYRANOSYL-VALIDOXYLAMINE-A
4'-O-BETA-D-GLUCOPYRANOSYL-VALIDOXYLAMINE-A
VALIDAMYCIN-H;6''-O-BETA-D-GLUCOPYRANOSYL-VALIDAMYCIN-A
BETA-D-ACARBOSE
ALPHA-D-ACARBOSE
1,6'-DI-N-(L-4-AMINO-2-HYDROXY-BUTYRYL)-KANAMYCIN
3''-N-ACETYLAMIKACIN
METHYL-2-ACETAMIDO-6-O-BENZYL-2-DEOXY-3-O-(BETA-D-GALACTOPYRANOSYL)-4-O-(ALPHA-L-RHAMNOPYRANOSYL)-BETA-D-GLUCOPYRANOSIDE
8-METHOXYCARBONYLOCTYL-BETA-D-GALACTOPYRANOSYL-(1->3)-2-DEOXY-2-(METHYL-BETA-D-GALACTOPYRANOSYLURONAMIDE)-BETA-D-GLUCOPYRANOSIDE
| Title | Journal or Book | Year |
|---|---|---|
| All eight possible mono-.BETA.-D-glucosides of validoxylamine A. I. Preparation and structure determination. | The Journal of Antibiotics | 1991 |